To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene WDR43TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
228 supporting clones for gene WDR43 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
C14847   .f-u 2697 to 2863 163 to 1   fully sequenced,   163/163
(100 %)
1 diff
(99.4 %id)
C14848   .f-u 2597 to 2838 9 to 246   fully sequenced,   238/246
(96 %)
24 diff
(90.3 %id)
C15566   .f-u 2587 to 2863 1 to 275       275/275
(100 %)
3 diff
(99.0 %id)
AA315159 colon .f-u 1574 to 2086 1 to 513   tiling clone,   513/513
(100 %)
0 diff
(100 %id)
AV704234 adrenal gland .f-u 2519 to 2864 646 to 300   AAA Submitted on the opposite strand 347/432
(80 %)
0 diff
(100 %id)
AK000836 adipose tissue .a 304 to 2004 1 to 1700   available from FLJ, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1700/1703
(99 %)
12 diff
(99.3 %id)
AW367262 head_neck .a 1199 to 1859 9 to 669       661/672
(98 %)
20 diff
(97.1 %id)
AW385246 leiomios .f-u 2138 to 2475 1 to 339       339/339
(100 %)
4 diff
(98.9 %id)
AW839070 leiomios .a 142 to 425 319 to 36       284/319
(89 %)
0 diff
(100 %id)
AW851124 colon .h-u 1 to 507 34 to 540   tiling clone,   507/540
(93 %)
6 diff
(98.9 %id)
AW853030 colon .a 286 to 870 583 to 1       583/632
(92 %)
8 diff
(98.8 %id)
AW949331   .f-u 1575 to 2099 1 to 522       522/522
(100 %)
3 diff
(99.5 %id)
AW967509   .g-u 448 to 1134 687 to 1   tiling clone, Submitted on the opposite strand 687/687
(100 %)
3 diff
(99.6 %id)
AW971528   .g-u 636 to 1134 499 to 1     Submitted on the opposite strand 499/535
(93 %)
10 diff
(98.2 %id)
AW999532 breast_normal .m-u 77 to 218 1 to 142       142/142
(100 %)
0 diff
(100 %id)
BE697647 colon .a 1016 to 1136 1 to 119       119/131
(90 %)
5 diff
(96.2 %id)
BE697650 colon .a 1020 to 1134 27 to 138       112/138
(81 %)
6 diff
(95.7 %id)
BE770563 prostate_tumor .n-u 1 to 269 12 to 279 I13L K22Q R31K K32G M33N ... tiling clone,   268/279
(96 %)
6 diff
(97.9 %id)
BF175990 blood .a 660 to 1069 1 to 407       407/407
(100 %)
5 diff
(98.8 %id)
BF736048 bladder_tumor .a 1160 to 1758 1 to 610       588/610
(96 %)
78 diff
(87.3 %id)
BI061925 uterus_tumor .k-u 1 to 470 1 to 470 exact tiling clone,   470/470
(100 %)
0 diff
(100 %id)
BI062483 uterus_tumor .k-u 7 to 507 501 to 1 exact tiling clone,   501/501
(100 %)
0 diff
(100 %id)
DA039505 bladder .a 29 to 490 2 to 463   capped   462/462
(100 %)
0 diff
(100 %id)
DA048836   .a 48 to 600 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
DA098222 cerebellum .a 22 to 584 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA238030 brain .a 48 to 632 2 to 591   capped   590/590
(100 %)
6 diff
(99.0 %id)
DA240106 brain .a 25 to 599 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA321916 hippocampus .f-u 1 to 563 2 to 565   tiling clone, to resequence, capped   564/564
(100 %)
3 diff
(99.5 %id)
DB309148 hippocampus .f-u 2398 to 2863 466 to 1   tiling clone, to resequence,   466/474
(98 %)
0 diff
(100 %id)
BX088756 breast .f-u 2280 to 2694 1 to 414       414/414
(100 %)
2 diff
(99.6 %id)
BX403617 placenta .a 44 to 1075 1 to 1024       1024/1033
(99 %)
26 diff
(97.5 %id)
AL515319 neuroblastoma, placenta .a 2775 to 3525 747 to 1   tiling clone,   747/747
(100 %)
15 diff
(98.0 %id)
AL515320 neuroblastoma, placenta .a 65 to 876 1 to 811       811/811
(100 %)
3 diff
(99.7 %id)
CN313100 embryonic stem cells, DMSO-treated H9 cellline .a 1417 to 2090 1 to 674       674/674
(100 %)
1 diff
(99.9 %id)
CN313101 embryonic stem cells, cell lines H1, H7, andH9 .a 1764 to 2451 15 to 703       689/703
(98 %)
8 diff
(98.9 %id)
CN313102 embryonic stem cells, cell lines H1, H7, andH9 .a 76 to 566 1 to 491       491/491
(100 %)
3 diff
(99.4 %id)
CN313103 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f-u 2650 to 2864 1 to 215   AAA   215/296
(72 %)
1 diff
(99.7 %id)
CN313104 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 58 to 869 8 to 819       812/819
(99 %)
7 diff
(99.2 %id)
CR612320 fetal liver .a 73 to 2258 1 to 2186   tiling clone,   2186/2186
(100 %)
0 diff
(100 %id)
CR618449 Placenta Cot 25-normalized .a 29 to 1089 1 to 1061       1061/1061
(100 %)
0 diff
(100 %id)
CR748401   .f-u 2038 to 2404 1 to 367       367/371
(98 %)
1 diff
(99.8 %id)
AL516198 brain, neuroblastoma, neuroblastoma cells .a 1362 to 2282 920 to 1       920/920
(100 %)
8 diff
(99.2 %id)
AL516199 brain, neuroblastoma, neuroblastoma cells .a 60 to 929 1 to 869       869/869
(100 %)
3 diff
(99.7 %id)
AL560415 B cells (Ramos cell line), B cells from Burkitt lymphoma .a 60 to 904 1 to 843       843/843
(100 %)
4 diff
(99.6 %id)
AL581865 B cells (Ramos cell line), B cells from Burkitt lymphoma .a 1385 to 2302 916 to 1       916/916
(100 %)
9 diff
(99.1 %id)
BX443629 T cells (Jurkat cell line) .a 50 to 776 1 to 735       735/735
(100 %)
23 diff
(96.9 %id)
BX357862 Placenta Cot 25-normalized .a 72 to 1039 1 to 963       963/1013
(95 %)
13 diff
(98.8 %id)
AL549324 placenta, Placenta Cot 25-normalized .a 29 to 571 1 to 542   fully sequenced,   542/542
(100 %)
3 diff
(99.5 %id)
AL573599 placenta, Placenta Cot 25-normalized .a 510 to 1089 580 to 1   fully sequenced,   580/580
(100 %)
7 diff
(98.8 %id)
BX340270 Placenta Cot 25-normalized .a 62 to 972 1 to 911       911/911
(100 %)
10 diff
(99.0 %id)
AL532396 brain, fetal liver, Liver, neuroblastoma cells .a 1363 to 2258 903 to 1       903/1024
(88 %)
62 diff
(94.0 %id)
AL532397 brain, fetal liver, Liver, neuroblastoma cells .a 73 to 1142 1 to 1056       1056/1056
(100 %)
21 diff
(98.1 %id)
BX411450 fetal liver, Liver .a 653 to 1498 856 to 1       857/887
(96 %)
39 diff
(95.7 %id)
BX432011 fetal liver, Liver .a 969 to 1678 1 to 710       710/887
(80 %)
9 diff
(99.0 %id)
CU452575 epidermis .c 1 to 579 597 to 19 E177G tiling clone, Submitted on the opposite strand 579/610
(94 %)
2 diff
(99.7 %id)
D26488   .a 27 to 3524 1 to 3496 exact tiling clone, available from KIAA,   3496/3500
(99 %)
6 diff
(99.9 %id)
D87716 bone marrow .a 521 to 3524 1 to 3004   available from KIAA,   3004/3004
(100 %)
9 diff
(99.8 %id)
DA473355   .a 544 to 1101 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA474078   .a 47 to 619 2 to 575   capped   574/575
(99 %)
2 diff
(99.7 %id)
AL036780 brain .f-u 2518 to 2863 28 to 374   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 347/374
(92 %)
5 diff
(98.7 %id)
AL708293 human skeletal muscle .a 464 to 1063 1 to 598       598/598
(100 %)
3 diff
(99.5 %id)
BX475447   .a 43 to 430 1 to 389       389/389
(100 %)
1 diff
(99.8 %id)
BX475682   .a 43 to 501 1 to 459       459/459
(100 %)
0 diff
(100 %id)
AL121450 melanoma (MeWo cell line) .a 1179 to 1543 1 to 365       365/365
(100 %)
2 diff
(99.5 %id)
BX496321 Liver .a 641 to 1152 1 to 512       512/512
(100 %)
1 diff
(99.9 %id)
BX502509 Liver .a 1080 to 1779 1 to 699       699/699
(100 %)
8 diff
(98.9 %id)
BX954765   .j-u 1 to 621 1 to 621 exact tiling clone,   621/621
(100 %)
3 diff
(99.6 %id)
DW448570 Liver .a 41 to 233 15 to 207       193/207
(93 %)
7 diff
(96.7 %id)
EH326676   .f-u 133 to 182 1 to 50   tiling clone,   50/50
(100 %)
0 diff
(100 %id)
FN066502 breast carcinoma .a 1188 to 1290 1 to 104       104/104
(100 %)
3 diff
(97.2 %id)
FN081259 breast carcinoma .f-u 2527 to 2616 1 to 90       90/91
(98 %)
1 diff
(99.0 %id)
FN138193 breast carcinoma .f-u 1586 to 1685 1 to 98       98/98
(100 %)
2 diff
(98.0 %id)
FN170053 breast carcinoma .f-u 1556 to 1657 1 to 99       99/99
(100 %)
3 diff
(97.0 %id)
G36918   .l-u 1 to 471 1 to 470 A63D     470/470
(100 %)
5 diff
(99.0 %id)
GD141692   .a 1289 to 1411 1 to 122       122/131
(93 %)
3 diff
(97.8 %id)
GD153854   .a 1293 to 1411 7 to 125       119/127
(93 %)
10 diff
(92.2 %id)
GD155882   .b 1303 to 1363 1 to 62   tiling clone,   62/62
(100 %)
2 diff
(96.8 %id)
D53186   .f-u 2587 to 2863 1 to 277   fully sequenced,   277/277
(100 %)
3 diff
(99.0 %id)
D60354   .f-u 2703 to 2863 161 to 1   fully sequenced,   161/161
(100 %)
1 diff
(99.4 %id)
D61035   .f-u 2587 to 2863 1 to 277       277/277
(100 %)
1 diff
(99.7 %id)
D57375   .f-u 2654 to 2871 1 to 218   tiling clone,   218/218
(100 %)
0 diff
(100 %id)
DB442514 testis .e 1 to 386 1 to 390   tiling clone,   390/390
(100 %)
12 diff
(97.0 %id)
DB507365 testis .a 1890 to 2299 1 to 409   AAA Submitted on the opposite strand 409/409
(100 %)
12 diff
(97.1 %id)
DB444020 testis .a 20 to 472 1 to 453       453/453
(100 %)
2 diff
(99.6 %id)
DB508928 testis .a 959 to 1405 1 to 447     Submitted on the opposite strand 447/447
(100 %)
9 diff
(98.0 %id)
DB515023 testis .a 393 to 824 1 to 432     Submitted on the opposite strand 432/432
(100 %)
13 diff
(97.0 %id)
DB455935 testis .e 64 to 559 1 to 496   tiling clone,   496/496
(100 %)
2 diff
(99.6 %id)
DB521358 testis .f-u 1333 to 1644 1 to 314 K4R K5E N6E E7* tiling clone, Submitted on the opposite strand 314/314
(100 %)
8 diff
(97.5 %id)
BP872899 embryonal kidney .a 57 to 635 1 to 578       578/582
(99 %)
4 diff
(99.4 %id)
CN482190 eye .a 81 to 714 1 to 634       634/634
(100 %)
1 diff
(99.9 %id)
R83248 breast .f-u 2300 to 2794 1 to 496       496/496
(100 %)
21 diff
(95.8 %id)
N68480 liver and spleen .l-u 1 to 471 1 to 470 A63D tiling clone, Submitted on the opposite strand 470/470
(100 %)
5 diff
(99.0 %id)
W19428 lung .f-u 1391 to 1839 1 to 449 exact tiling clone,   449/449
(100 %)
2 diff
(99.6 %id)
AA682507 liver and spleen .h-u 443 to 894 452 to 1 H15Y tiling clone,   452/452
(100 %)
2 diff
(99.6 %id)
AA044399 uterus .f-u 1410 to 1642 234 to 1       234/240
(97 %)
1 diff
(99.6 %id)
AA156487 colon, tumor .f-u 1477 to 1943 469 to 1       469/473
(99 %)
2 diff
(99.6 %id)
AA156138 colon, tumor .a 1433 to 1856 1 to 424       424/425
(99 %)
1 diff
(99.8 %id)
AA251235 germinal center B cell .g-u 661 to 1135 475 to 1   tiling clone,   475/475
(100 %)
1 diff
(99.8 %id)
AA251368 germinal center B cell .g-u 1 to 435 1 to 434 exact tiling clone,   434/434
(100 %)
1 diff
(99.8 %id)
AA460556   .g-u 36 to 344 1 to 309 exact tiling clone,   309/309
(100 %)
0 diff
(100 %id)
AA460557   .g-u 683 to 1139 457 to 1   tiling clone,   457/457
(100 %)
1 diff
(99.8 %id)
AA468890 colon .a 755 to 1405 650 to 1       650/650
(100 %)
15 diff
(97.7 %id)
AA470934 alveolar rhabdomyosarcoma .f-u 2654 to 2838 186 to 2       185/188
(98 %)
0 diff
(100 %id)
AA580434 colon, colon tumor .a 1808 to 2306 499 to 1       499/499
(100 %)
2 diff
(99.6 %id)
AA582856 germ cell tumor .b 713 to 1347 636 to 1       636/636
(100 %)
2 diff
(99.7 %id)
AA582857 germ cell tumor .b 713 to 1340 629 to 1   tiling clone,   629/629
(100 %)
2 diff
(99.7 %id)
AA834858 ovary .g-u 847 to 1135 1 to 289   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 289/289
(100 %)
0 diff
(100 %id)
AA865370 pooled germ cell tumors .f-u 2541 to 2863 341 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 323/323
(100 %)
0 diff
(100 %id)
AI472170 pooled .f-u 2424 to 2863 474 to 36   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 439/439
(100 %)
6 diff
(98.7 %id)
AI457359 colon, moderately-differentiated adenocarcinoma .a 1709 to 2307 600 to 1       600/600
(100 %)
8 diff
(98.7 %id)
AI651834 pooled germ cell tumors .f-u 2533 to 2821 1 to 289     Submitted on the opposite strand 289/289
(100 %)
3 diff
(99.0 %id)
AW009935 colon .f-u 1438 to 1645 208 to 1       208/208
(100 %)
0 diff
(100 %id)
AI961936 adenocarcinoma, Pancreas .a 1585 to 1989 404 to 1       404/404
(100 %)
2 diff
(99.6 %id)
AW088023 esophagus, squamous cell carcinoma .a 1409 to 1989 581 to 1       581/581
(100 %)
2 diff
(99.7 %id)
AW118220 pooled .a 1748 to 2304 563 to 7       557/563
(98 %)
1 diff
(99.9 %id)
AW242347 Kidney .f-u 2699 to 2862 184 to 20   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 165/165
(100 %)
8 diff
(95.2 %id)
AW276385 lung, two pooled squamous cell carcinomas .a 1682 to 2316 635 to 1       635/635
(100 %)
4 diff
(99.4 %id)
AW593733 pooled germ cell tumors .f-u 2625 to 2869 256 to 12   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 245/245
(100 %)
0 diff
(100 %id)
BU431079 lymph .a 193 to 615 8 to 431       423/431
(98 %)
17 diff
(96.1 %id)
BE349630 malignant melanoma, metastatic to lymphnode, skin .a 1493 to 1989 497 to 1       497/503
(98 %)
1 diff
(99.9 %id)
BE384100 melanotic melanoma, skin .a 70 to 355 1 to 284       284/284
(100 %)
2 diff
(99.3 %id)
BE408569 choriocarcinoma, placenta .a 613 to 1275 1 to 658       659/659
(100 %)
6 diff
(99.1 %id)
BF222976 pooled germ cell tumors .m-u 1 to 362 362 to 1 exact tiling clone,   362/362
(100 %)
2 diff
(99.5 %id)
BF031447 hypernephroma, Kidney .a 1860 to 2560 9 to 705       697/828
(84 %)
28 diff
(96.7 %id)
BE796672 lung, small cell carcinoma .a 800 to 1587 1 to 779       779/925
(84 %)
23 diff
(97.6 %id)
BF025694 melanotic melanoma, skin .a 68 to 801 1 to 734       734/798
(91 %)
11 diff
(98.7 %id)
BF131103 hypernephroma, Kidney .f-u 1924 to 2514 1 to 587       587/868
(67 %)
15 diff
(98.3 %id)
BF699660 brain, primitive neuroectoderm .a 46 to 745 1 to 700       698/881
(79 %)
28 diff
(96.9 %id)
BF794950 lymph, lymphoma, cell line .a 50 to 815 1 to 763   AAA   763/763
(100 %)
11 diff
(98.6 %id)
BF965470 Bone, osteosarcoma, cell line .a 716 to 1352 1 to 635       635/635
(100 %)
6 diff
(99.1 %id)
BG036013 adenocarcinoma, cell line, Liver .f-u 1770 to 2524 1 to 751   tiling clone,   751/832
(90 %)
24 diff
(97.2 %id)
BG104156 melanotic melanoma, skin .a 49 to 660 1 to 615       615/916
(67 %)
25 diff
(97.3 %id)
BG323976 Kidney, renal cell adenocarcinoma .a 53 to 880 1 to 829       829/854
(97 %)
23 diff
(97.4 %id)
BG475265 melanotic melanoma, skin .a 49 to 661 1 to 611       611/617
(99 %)
7 diff
(98.9 %id)
BG476401 melanotic melanoma, skin .a 49 to 872 1 to 825       825/826
(99 %)
3 diff
(99.7 %id)
BG477404 melanotic melanoma, skin .a 49 to 904 1 to 871       871/918
(94 %)
31 diff
(96.7 %id)
BG503183 embryonal carcinoma, testis .a 1687 to 2243 1 to 558       558/558
(100 %)
4 diff
(99.3 %id)
BC024234 Testis, embryonal carcinoma .a 1687 to 3523 4 to 1839   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 1836/1837
(99 %)
4 diff
(99.8 %id)
BG532365 embryonal carcinoma, testis .a 1687 to 2462 1 to 787   available from MGC,   787/791
(99 %)
24 diff
(97.0 %id)
BG674140 skin .f-u 1729 to 2510 1 to 784       784/1045
(75 %)
6 diff
(99.5 %id)
BG676498 skin, squamous cell carcinoma .a 1803 to 2516 1 to 715       715/775
(92 %)
5 diff
(99.4 %id)
BG743644 skin .a 1068 to 1854 1 to 786       786/786
(100 %)
3 diff
(99.7 %id)
BG760680 melanotic melanoma, high MDR (cell line), skin .b 1 to 787 1 to 786   tiling clone,   786/786
(100 %)
6 diff
(99.3 %id)
BC033206 Muscle, rhabdomyosarcoma .a 305 to 1405 11 to 1111   available from MGC, AAA   1101/1101
(100 %)
2 diff
(99.9 %id)
BG825535 muscle, rhabdomyosarcoma .a 294 to 1143 1 to 843   available from MGC,   843/939
(89 %)
17 diff
(98.2 %id)
BG826406 muscle, rhabdomyosarcoma .a 294 to 1073 1 to 779       779/783
(99 %)
3 diff
(99.7 %id)
BI835496 pooled pancreas and spleen .a 68 to 859 1 to 805       805/809
(99 %)
48 diff
(94.1 %id)
BM011908 brain, neuroblastoma, cell line .a 510 to 1290 1 to 785       785/786
(99 %)
17 diff
(97.9 %id)
BM541477 leiomyosarcoma, uterus .a 54 to 899 15 to 878       864/1096
(78 %)
21 diff
(98.1 %id)
BM454777 leiomyosarcoma, uterus .a 766 to 1469 1 to 715       715/1071
(66 %)
19 diff
(98.3 %id)
BM473523 duodenal adenocarcinoma, cell line, small intestine .a 811 to 1799 1 to 988       988/1072
(92 %)
12 diff
(98.9 %id)
BQ053985 blood, natural killer cells, cell line .a 45 to 970 1 to 935       935/1048
(89 %)
18 diff
(98.3 %id)
BU076590 Pancreas, Purified pancreatic islet .a 38 to 622 1 to 585       585/585
(100 %)
7 diff
(98.9 %id)
BQ229502 embryonal carcinoma, cell line, testis .a 314 to 972 1 to 658       658/791
(83 %)
4 diff
(99.5 %id)
BQ430991 melanotic melanoma, skin .a 56 to 537 10 to 491       482/856
(56 %)
12 diff
(98.6 %id)
BU176490 eye, retinoblastoma .a 1777 to 2653 24 to 903       880/903
(97 %)
9 diff
(99.1 %id)
BU188794 melanotic melanoma, skin .a 267 to 815 1 to 549   AAA   549/549
(100 %)
0 diff
(100 %id)
BU508687 leiomyosarcoma, uterus .a 1448 to 2257 12 to 834       823/948
(86 %)
14 diff
(98.6 %id)
BU520870 leiomyosarcoma, uterus .a 467 to 1232 1 to 774       774/876
(88 %)
13 diff
(98.6 %id)
CX867035 embryonic stem .f-u 2517 to 2863 1 to 347   AAA Submitted on the opposite strand 347/347
(100 %)
0 diff
(100 %id)
CX867107 embryonic stem .f-u 2517 to 2863 375 to 29   AAA Submitted on the opposite strand 347/347
(100 %)
0 diff
(100 %id)
CV802065 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .i-u 1 to 737 1 to 728 exact tiling clone,   728/847
(85 %)
11 diff
(98.8 %id)
CX755205 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 80 to 805 1 to 726     Submitted on the opposite strand 726/726
(100 %)
2 diff
(99.8 %id)
CD515567 White Matter .a 64 to 904 1 to 843       843/869
(97 %)
4 diff
(99.6 %id)
CD639866 pooled .f-u 1453 to 2084 1 to 626       626/729
(85 %)
9 diff
(98.8 %id)
DA607422   .a 25 to 572 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
DA617226   .a 25 to 588 2 to 566   capped   565/565
(100 %)
3 diff
(99.5 %id)
TI_57166042   .a 63 to 859 54 to 864       809/868
(93 %)
25 diff
(97.2 %id)
TI_59381092   .a 511 to 1290 96 to 879       784/785
(99 %)
16 diff
(98.0 %id)
CB126579 Liver .a 512 to 974 1 to 463       463/463
(100 %)
1 diff
(99.8 %id)
CB126726 Liver .a 512 to 990 1 to 479       479/479
(100 %)
3 diff
(99.4 %id)
CB144007 Liver .a 813 to 1203 1 to 393       393/393
(100 %)
3 diff
(99.3 %id)
DA645333   .a 22 to 584 2 to 564   capped   563/565
(99 %)
1 diff
(99.9 %id)
DA648559   .a 48 to 592 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA654109   .a 48 to 645 2 to 600   capped   599/599
(100 %)
1 diff
(99.9 %id)
DA654485   .a 1 to 564 2 to 565   tiling clone, capped   564/564
(100 %)
1 diff
(99.9 %id)
DA667581 esophagus .a 23 to 590 2 to 570   capped   569/569
(100 %)
4 diff
(99.3 %id)
DA679092   .a 53 to 612 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
NM_015131.1   .a 24 to 3524 1 to 3501 exact RefSeq,   3501/3501
(100 %)
0 diff
(100 %id)
DA726708   .a 23 to 549 2 to 529   capped   528/528
(100 %)
1 diff
(99.9 %id)
DA728843   .a 48 to 894 2 to 852   capped   851/853
(99 %)
13 diff
(98.5 %id)
DB353889   .a 1494 to 1989 496 to 1       496/547
(90 %)
8 diff
(98.6 %id)
DA755710   .a 53 to 386 2 to 335   capped   334/334
(100 %)
0 diff
(100 %id)
DA798778 brain .a 47 to 589 2 to 544   capped   543/543
(100 %)
2 diff
(99.7 %id)
DA804653 brain .a 31 to 594 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DA819994   .a 22 to 572 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
DA822057 pericardium .a 37 to 611 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA843281 placenta .a 22 to 588 2 to 569   capped   568/568
(100 %)
4 diff
(99.3 %id)
CR988625 T-Lymphocytes .a 77 to 802 1 to 727       727/729
(99 %)
5 diff
(99.4 %id)
BM738889 Ascites, stomach .a 1854 to 2376 1 to 524       522/524
(99 %)
3 diff
(99.5 %id)
BM739934 Ascites, stomach .a 1809 to 2391 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BM756514 Ascites, stomach .a 1809 to 1994 1 to 186       186/186
(100 %)
1 diff
(99.5 %id)
BM754426 stomach .a 1226 to 1667 1 to 441       441/441
(100 %)
2 diff
(99.6 %id)
BM788301 stomach .a 52 to 750 1 to 698       698/698
(100 %)
3 diff
(99.6 %id)
BM796822 Ascites, stomach .a 714 to 1329 1 to 615       615/615
(100 %)
2 diff
(99.7 %id)
BM825148 Ascites, stomach .a 584 to 1292 1 to 709       709/709
(100 %)
1 diff
(99.9 %id)
BQ083173 Ascites, stomach .a 294 to 657 1 to 363       363/363
(100 %)
6 diff
(98.4 %id)
DA912446   .a 37 to 603 2 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
DA924225 small intestine .a 53 to 584 2 to 536   capped   535/535
(100 %)
4 diff
(99.3 %id)
DA934422 Spleen .a 48 to 630 2 to 584   capped   583/583
(100 %)
3 diff
(99.5 %id)
DA936798 Spleen .a 25 to 604 2 to 588   capped   587/587
(100 %)
7 diff
(98.9 %id)
DA943836 Spleen .a 25 to 596 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
T29045 prostate gland .a 1424 to 1716 1 to 293       293/293
(100 %)
0 diff
(100 %id)
DB024057 testis .e 24 to 581 2 to 559 exact tiling clone, capped   558/558
(100 %)
2 diff
(99.7 %id)
DB059397 testis .d 1 to 542 2 to 543 exact tiling clone, capped   542/542
(100 %)
2 diff
(99.7 %id)
DB091547 testis .a 25 to 572 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DB122812 thymus .a 25 to 661 2 to 638   capped   637/646
(98 %)
1 diff
(99.9 %id)
DB163799 thymus .a 23 to 592 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
TI_149276938   .a 1492 to 2043 622 to 71   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 552/763
(72 %)
2 diff
(99.8 %id)
TI_149305042   .f-u 2277 to 2863 709 to 130   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 580/901
(64 %)
8 diff
(99.2 %id)
TI_154152851   .a 193 to 802 79 to 688       609/667
(91 %)
32 diff
(95.3 %id)
TI_159695999   .a 1789 to 2310 623 to 101       523/1073
(48 %)
14 diff
(98.7 %id)
DB219828 trachea .a 48 to 596 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DB229759 trachea .a 25 to 613 2 to 589   capped   588/588
(100 %)
3 diff
(99.5 %id)
DB233960 trachea .a 25 to 625 2 to 602   capped   601/601
(100 %)
1 diff
(99.9 %id)
DB235303 trachea .a 23 to 486 2 to 465   capped   464/464
(100 %)
1 diff
(99.8 %id)
DB238221 trachea .a 37 to 604 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BM969052 lung, Primary Lung Epithelial Cells .a 1492 to 2043 557 to 6   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 552/561
(98 %)
2 diff
(99.7 %id)
BM978525 lung, Primary Lung Epithelial Cells .f-u 2277 to 2863 598 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 580/606
(95 %)
8 diff
(98.7 %id)
CA312966 Human Lung Epithelial cells, lung .f-u 2518 to 2859 539 to 198   AAA   342/557
(61 %)
0 diff
(100 %id)
CA311794 Human Lung Epithelial cells, lung .f-u 2522 to 2682 1 to 161     Submitted on the opposite strand 161/170
(94 %)
1 diff
(99.5 %id)
CB250702 Human Lung Epithelial cells, lung .f-u 2521 to 2863 361 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 343/376
(91 %)
0 diff
(100 %id)
BM701460 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f-u 2526 to 2862 16 to 352       337/352
(95 %)
8 diff
(97.8 %id)
BM716834 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f-u 2526 to 2869 16 to 359   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 344/359
(95 %)
6 diff
(98.4 %id)
CA429276 Cell Line, Chondrosarcoma .a 775 to 1405 646 to 17   AAA   630/630
(100 %)
4 diff
(99.4 %id)
TI_151752468   .f-u 2525 to 2869 450 to 105   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 346/1262
(27 %)
1 diff
(100.0 %id)
DB251435 uterus .a 48 to 584 2 to 539   capped   538/538
(100 %)
3 diff
(99.5 %id)
DB268222 uterus .a 25 to 564 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DB276454 uterus .a 25 to 560 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
DB280860 uterus .a 39 to 580 2 to 544   capped   543/543
(100 %)
2 diff
(99.7 %id)
BX109124 ovary, tumor, 5 pooled (see description) .a 512 to 974 1 to 463   AAA   463/463
(100 %)
1 diff
(99.8 %id)
BP872388 embryonal kidney .a 512 to 990 1 to 479     This clone was ignored 479/479
(100 %)
3 diff
(99.4 %id)
BP872775 embryonal kidney .a 813 to 1203 1 to 393     This clone was ignored 393/393
(100 %)
3 diff
(99.3 %id)
AI609327 ovary, tumor, 5 pooled (see description) .a 22 to 584 2 to 564       563/565
(99 %)
1 diff
(99.9 %id)
BG032708 breast, mammary adenocarcinoma, cell line .a 48 to 592 2 to 547     Suspected internal deletion, this clone was ignored 546/546
(100 %)
1 diff
(99.9 %id)
BG142241 Islets of Langerhans, Pancreas .a 48 to 645 2 to 600     This clone was ignored 599/599
(100 %)
1 diff
(99.9 %id)
CB133931 Liver .a 1 to 564 2 to 565   tiling clone, Suspected internal deletion, this clone was ignored 564/564
(100 %)
1 diff
(99.9 %id)
DB071875 testis .a 23 to 590 2 to 570   capped   569/569
(100 %)
4 diff
(99.3 %id)
DB340265 testis .a 53 to 612 2 to 562       561/561
(100 %)
2 diff
(99.7 %id)
NM_015131.1   .a 24 to 3524 1 to 3501 exact RefSeq,   3501/3501
(100 %)
0 diff
(100 %id)
DA726708   .a 23 to 549 2 to 529   capped   528/528
(100 %)
1 diff
(99.9 %id)
DA728843   .a 48 to 894 2 to 852   capped   851/853
(99 %)
13 diff
(98.5 %id)
DB353889   .a 1494 to 1989 496 to 1       496/547
(90 %)
8 diff
(98.6 %id)
DA755710   .a 53 to 386 2 to 335   capped   334/334
(100 %)
0 diff
(100 %id)
DA798778 brain .a 47 to 589 2 to 544   capped   543/543
(100 %)
2 diff
(99.7 %id)
DA804653 brain .a 31 to 594 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DA819994   .a 22 to 572 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
DA822057 pericardium .a 37 to 611 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA843281 placenta .a 22 to 588 2 to 569   capped   568/568
(100 %)
4 diff
(99.3 %id)
CR988625 T-Lymphocytes .a 77 to 802 1 to 727       727/729
(99 %)
5 diff
(99.4 %id)
BM738889 Ascites, stomach .a 1854 to 2376 1 to 524       522/524
(99 %)
3 diff
(99.5 %id)
BM738889 Ascites, stomach .a 1854 to 2376 1 to 524       522/524
(99 %)
3 diff
(99.5 %id)
BM739934 Ascites, stomach .a 1809 to 2391 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BM739934 Ascites, stomach .a 1809 to 2391 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BM756514 Ascites, stomach .a 1809 to 1994 1 to 186       186/186
(100 %)
1 diff
(99.5 %id)
BM756514 Ascites, stomach .a 1809 to 1994 1 to 186       186/186
(100 %)
1 diff
(99.5 %id)
BM754426 stomach .a 1226 to 1667 1 to 441       441/441
(100 %)
2 diff
(99.6 %id)
BM788301 stomach .a 52 to 750 1 to 698       698/698
(100 %)
3 diff
(99.6 %id)
BM796822 Ascites, stomach .a 714 to 1329 1 to 615       615/615
(100 %)
2 diff
(99.7 %id)
BM796822 Ascites, stomach .a 714 to 1329 1 to 615       615/615
(100 %)
2 diff
(99.7 %id)
BM825148 Ascites, stomach .a 584 to 1292 1 to 709       709/709
(100 %)
1 diff
(99.9 %id)
BM825148 Ascites, stomach .a 584 to 1292 1 to 709       709/709
(100 %)
1 diff
(99.9 %id)
BQ083173 Ascites, stomach .a 294 to 657 1 to 363       363/363
(100 %)
6 diff
(98.4 %id)
BQ083173 Ascites, stomach .a 294 to 657 1 to 363       363/363
(100 %)
6 diff
(98.4 %id)
DA912446   .a 37 to 603 2 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
DA924225 small intestine .a 53 to 584 2 to 536   capped   535/535
(100 %)
4 diff
(99.3 %id)
DA934422 Spleen .a 48 to 630 2 to 584   capped   583/583
(100 %)
3 diff
(99.5 %id)
DA936798 Spleen .a 25 to 604 2 to 588   capped   587/587
(100 %)
7 diff
(98.9 %id)
DA943836 Spleen .a 25 to 596 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
T29045 prostate gland .a 1424 to 1716 1 to 293       293/293
(100 %)
0 diff
(100 %id)
DB024057 testis .e 24 to 581 2 to 559 exact tiling clone, capped   558/558
(100 %)
2 diff
(99.7 %id)
DB059397 testis .d 1 to 542 2 to 543 exact tiling clone, capped   542/542
(100 %)
2 diff
(99.7 %id)
DB091547 testis .a 25 to 572 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DB122812 thymus .a 25 to 661 2 to 638   capped   637/646
(98 %)
1 diff
(99.9 %id)
DB163799 thymus .a 23 to 592 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
TI_149276938   .a 1492 to 2043 622 to 71   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 552/763
(72 %)
2 diff
(99.8 %id)
TI_149305042   .f-u 2277 to 2863 709 to 130   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 580/901
(64 %)
8 diff
(99.2 %id)
TI_154152851   .a 193 to 802 79 to 688       609/667
(91 %)
32 diff
(95.3 %id)
TI_159695999   .a 1789 to 2310 623 to 101       523/1073
(48 %)
14 diff
(98.7 %id)
DB219828 trachea .a 48 to 596 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DB229759 trachea .a 25 to 613 2 to 589   capped   588/588
(100 %)
3 diff
(99.5 %id)
DB233960 trachea .a 25 to 625 2 to 602   capped   601/601
(100 %)
1 diff
(99.9 %id)
DB235303 trachea .a 23 to 486 2 to 465   capped   464/464
(100 %)
1 diff
(99.8 %id)
DB238221 trachea .a 37 to 604 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BM969052 lung, Primary Lung Epithelial Cells .a 1492 to 2043 557 to 6   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 552/561
(98 %)
2 diff
(99.7 %id)
BM969052 lung, Primary Lung Epithelial Cells .a 1492 to 2043 557 to 6   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 552/561
(98 %)
2 diff
(99.7 %id)
BM978525 lung, Primary Lung Epithelial Cells .f-u 2277 to 2863 598 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 580/606
(95 %)
8 diff
(98.7 %id)
BM978525 lung, Primary Lung Epithelial Cells .f-u 2277 to 2863 598 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 580/606
(95 %)
8 diff
(98.7 %id)
CA312966 Human Lung Epithelial cells, lung .f-u 2518 to 2859 539 to 198   AAA   342/557
(61 %)
0 diff
(100 %id)
CA312966 Human Lung Epithelial cells, lung .f-u 2518 to 2859 539 to 198   AAA   342/557
(61 %)
0 diff
(100 %id)
CA311794 Human Lung Epithelial cells, lung .f-u 2522 to 2682 1 to 161     Submitted on the opposite strand 161/170
(94 %)
1 diff
(99.5 %id)
CA311794 Human Lung Epithelial cells, lung .f-u 2522 to 2682 1 to 161     Submitted on the opposite strand 161/170
(94 %)
1 diff
(99.5 %id)
CB250702 Human Lung Epithelial cells, lung .f-u 2521 to 2863 361 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 343/376
(91 %)
0 diff
(100 %id)
CB250702 Human Lung Epithelial cells, lung .f-u 2521 to 2863 361 to 19   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 343/376
(91 %)
0 diff
(100 %id)
BM701460 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f-u 2526 to 2862 16 to 352       337/352
(95 %)
8 diff
(97.8 %id)
BM701460 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f-u 2526 to 2862 16 to 352       337/352
(95 %)
8 diff
(97.8 %id)
BM716834 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f-u 2526 to 2869 16 to 359   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 344/359
(95 %)
6 diff
(98.4 %id)
BM716834 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f-u 2526 to 2869 16 to 359   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 344/359
(95 %)
6 diff
(98.4 %id)
CA429276 Cell Line, Chondrosarcoma .a 775 to 1405 646 to 17   AAA   630/630
(100 %)
4 diff
(99.4 %id)
CA429276 Cell Line, Chondrosarcoma .a 775 to 1405 646 to 17   AAA   630/630
(100 %)
4 diff
(99.4 %id)
TI_151752468   .f-u 2525 to 2869 450 to 105   AAA Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base) 346/1262
(27 %)
1 diff
(100.0 %id)
DB251435 uterus .a 48 to 584 2 to 539   capped   538/538
(100 %)
3 diff
(99.5 %id)
DB268222 uterus .a 25 to 564 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DB276454 uterus .a 25 to 560 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
DB280860 uterus .a 39 to 580 2 to 544   capped   543/543
(100 %)
2 diff
(99.7 %id)
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g-u, .h-u, .i-u, .j-u, .k-u, .l-u, .m-u, .n-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C